Epmedin C is primarily used in pharmaceutical research due to its bioactive properties. It exhibits strong antiviral activity, particularly against certain enveloped viruses, making it a candidate for development in antiviral therapies. Studies suggest it may interfere with viral entry into host cells by inhibiting membrane fusion processes. Additionally, Epmedin C has shown potential in immunomodulatory applications, where it can influence cytokine production and support immune response regulation. Its natural origin and specific mechanism of action also make it a valuable lead compound in designing new therapeutic agents for infectious diseases. Research is ongoing to explore its efficacy and safety in clinical settings.